Pharmacokinetics of xamoterol after intravenous and oral administration to patients with chronic heart failure

摘要

The pharmacokinetics of xamoterol, a β-adrenergic partial agonist under clinical evaluation for the treatment of mild to moderate heart failure, have been studied in 8 cardiac failure patients (NYHA Class II) of mean age 62 years